Foreign Product Alert
2007-87
July 16, 2007
For immediate release
Health Canada is advising consumers not to use the following product listed in the table below due to concerns about possible side-effects. More info
Dai Dai Hua Jiao Nang, Darling Capsules, Dali Capsules, Spanish Fly Capsules, an unnamed product
| Date of alert |
July 16, 2007 |
| Source of Alert |
Medsafe (New Zealand health regulatory authority) |
| Product Names |
Dai Dai Hua Jiao Nang, Darling Capsules, Dali Capsules, Spanish Fly Capsules, an unnamed product |
| Manufacturer / Place of Origin |
Asia |
| Products Description |
Darling Capsules, Dali Capsules, Spanish Fly Capsules, and an unnamed product listed in a recent Medsafe advisory are marketed as treatments for erectile dysfunction. The product Dai Dai Hua Jiao Nang is marketed for weight loss.
Darling Capsules
- packaged in silver foil with green print
Dali Capsules
- packaged in silver foil with green print
Spanish Fly Capsules
- packaged in silver foil with green print
An unnamed product
- orange capsules packaged in silver foil with green print on back of package
Front
Back
Dai Dai Hua Jiao Nang
- packaged in silver foil with blue and lavender print
|
| Reason for Warning |
Medsafe, the New Zealand health regulatory authority, advised the public not to use the products Darling Capsules, Dali Capsules, Spanish Fly Capsules, and an unnamed product, because they were found to contain sildenafil. Medsafe also advised the public not to use the product Dai Dai Hua Jiao Nang because it was found to contain sibutramine.
Sildenafil and sibutramine are prescription medications indicated for treatment of erectile dysfunction and obesity, respectively. They should only be used under the supervision of a health care professional. |
| Possible Side Effects |
Side effects associated with sildenafil citrate include headache, flushing, gastrointestinal disorders, penile tissue damage, visual disturbances, and inflammation of the mucous membrane of the nose.
Products containing sildenafil citrate should not be used by anyone taking a nitrate medication, as the combination could lead to potentially life-threatening low blood pressure.
Sibutramine is the active ingredient in a prescription drug marketed in Canada for the treatment of obesity. It should only be used under the supervision of a health care professional. Its side effects may include increased heart rate and blood pressure, and headaches. |
-30-
Media Inquiries:
Alastair Sinclair
Health Canada
(613) 946-4250
This product is not authorized for sale in Canada and has not been found in the Canadian marketplace. However, it is possible this product could be purchased by Canadians travelling abroad or has been brought into Canada through personal importation by travellers or purchased over the Internet.
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed in the table in the Canadian marketplace.
For more information about the information contained in this advisory, please contact Health Canada's public inquiries line at (613) 957-2991 or toll-free at 1-866-225-0709.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.
|
